InvestSMART

Proteomics International Laboratories Ltd (ASX: PIQ) - Announcements

Current share price for PIQ : $0.155 0.015 (8.82%)+

ASX company news and announcements for Proteomics International Laboratories Ltd (PIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Proteomics International Laboratories Ltd (PIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Proteomics International Laboratories Ltd (PIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Proteomics International Laboratories Ltd (PIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$26 Appendix 4C - March 2016 Quarterly Report 26 Apr 2016 9:15AM $0.200 $0.155 fallen by 22.50%
$26 Proteomics to expand operations in Indian Market 14 Apr 2016 11:55AM $0.255 $0.155 fallen by 39.22%
$26 Appendix 3B - Release from escrow 8 Apr 2016 6:10PM $0.245 $0.155 fallen by 36.73%
$26 Appendix 3B - Exercise of Options 31 Mar 2016 7:00PM $0.240 $0.155 fallen by 35.42%
$26 Proteomics commences Therapeutic Drug Discovery Program 23 Mar 2016 9:38AM $0.240 $0.155 fallen by 35.42%
$26 Release from escrow 22 Mar 2016 7:07PM $0.240 $0.155 fallen by 35.42%
$26 PromarkerD Update 7 Mar 2016 9:33AM $0.250 $0.155 fallen by 38%
$26 Appendix 4D and Interim Financial Report 26 Feb 2016 2:46PM $0.320 $0.155 fallen by 51.56%
$26 Appendix 3B 16 Feb 2016 5:05PM $0.265 $0.155 fallen by 41.51%
$26 New Company Website and Corporate Video 9 Feb 2016 8:21AM $0.275 $0.155 fallen by 43.64%
$26 Appendix 4C - December 2015 Quarterly Report 21 Jan 2016 11:13AM $0.320 $0.155 fallen by 51.56%
$26 Appendix 3B - Exercise of Options 7 Dec 2015 5:20PM $0.310 $0.155 fallen by 50%
$26 Appendix 3B - Exercise of options 27 Nov 2015 5:46PM $0.380 $0.155 fallen by 59.21%
$26 Results of Meeting 20 Nov 2015 3:35PM $0.350 $0.155 fallen by 55.71%
$26 Proteomics AGM Presentation 20 Nov 2015 12:11PM $0.350 $0.155 fallen by 55.71%
$26 Proteomics International receives R&D Tax Incentive 18 Nov 2015 9:13AM $0.400 $0.155 fallen by 61.25%
$26 Appendix 3B - Issue of Shortfall Options 6 Nov 2015 1:42PM $0.425 $0.155 fallen by 63.53%
$26 Proteomics Targets Key Asian Markets 4 Nov 2015 10:01AM $0.405 $0.155 fallen by 61.73%
$26 Appendix 4C - September 2015 Quarterly Report 30 Oct 2015 3:36PM $0.480 $0.155 fallen by 67.71%
$26 Proteomics granted US Patent for Diagnostic Test 27 Oct 2015 9:16AM $0.340 $0.155 fallen by 54.41%
$26 Proteomics Technical Presentation 26 Oct 2015 10:12AM $0.320 $0.155 fallen by 51.56%
$26 Notice of Annual General Meeting/Proxy Form 20 Oct 2015 8:09PM $0.310 $0.155 fallen by 50%
$26 Initial Director's Interest Notice 19 Oct 2015 7:42PM $0.310 $0.155 fallen by 50%
$26 Change of Directors' Interest Notices 19 Oct 2015 7:28PM $0.310 $0.155 fallen by 50%
$26 Proteomics International Wins WA Industry and Export Award 19 Oct 2015 11:05AM $0.260 $0.155 fallen by 40.38%

626 - 650 of 688 results

Page 26 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.